Infectious Disease
- 2019-nCoV Patient pathway 2020 – RHCG clinical policy
- Antibiotic management of Group A Streptococcus (GAS, Strep. pyogenes) infection in children
- Booster immunisation of patients treated with standard dose chemotherapy
- Chickenpox
- Clostridioides (Clostridium) Difficile Infection (CDI) in children: diagnosis and management
- Empiric infection management guidelines, paediatrics, Primary Care
- Greenbook Chapter 14a: COVID-19
- Guidelines for the management of paediatric line-related sepsis
- Immunisation best practice guideline
- Infection prevention and control homepage (NHSGGC website)
- Isolates reported as 'I' (susceptible increased exposure) - dosing schedules for neonates and children
- Malaria treatment guidelines, paediatrics
- Management of monkeypox, RHC Glasgow
- Management of neutropenia & fever: antibiotic policy
- MERS - Middle East Respiratory Syndrome - RHC ED patient pathway guidance
- Paediatric IV to oral antibiotic switch therapy (IVOST) guideline
- Paediatric pathway for administration of Sotrovimab
- Possible Viral Haemorrhagic Fever (VHF) Management in Adults and Children
- Protected Antibiotic Policy - Royal Hospital for Children (RHC)
- Rabies risk assessment and treatment following bat exposure
- Scottish paediatric and adolescent infection and immunology network pathway for nMABs for non-hospitalised adolescents with COVID-19
- Scottish Paediatric Consensus Treatment Guideline for Covid-19 and related conditions
- Varicella zoster infection (chickenpox): management in children
- Viral Haemorrhagic Fever (VHF) patient pathway 2021 (Paediatric ED)
- West of Scotland Paediatric Hepatitis Pathway